Skip to main content
SpringerLink
Log in

Eradication of Helicobacter pylori in the Treatment of Uncomplicated Peptic Ulcer Disease

  • Review Article
  • Interventions & Outcomes
  • Published:
Disease Management and Health Outcomes

Abstract

At least 95% of patients with duodenal ulcers and 80% of patients with gastric ulcers are infected with Helicobacter pylori. H. pylori is clearly recognised as the major culprit involved in the pathophysiology of peptic ulcer disease. Since eradication of this organism has prevented ulcer recurrence, there have been radical changes in evaluating and treating patients with this disease. This review is a summary of the literature obtained from a MEDLINE search (1966 to 1997) of the English-language literature pertaining to H. pylori and peptic ulcer disease. All articles related to the aetiology or treatment of H. pylori-associated peptic ulcer disease were considered in the review and information was selected at the discretion of the authors.

This review discusses the epidemiology, pathogenesis, clinical presentation, clinical evaluation and effective treatment options concerning peptic ulcer disease and H. pylori infection. With the discovery of the association between peptic ulcer disease and H. pylori, many peptic ulcers can now be cured.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Soll AH. Gastric, duodenal, and stress ulcer. In: Sleisenger M, Fordtran J, editors. Gastrointestinal disease: pathophysiology, diagnosis, management. 5th ed. Philadelphia: WB Saunders, 1993: 580–679.

    Google Scholar 

  2. Kurata J, Nogawa A, Watanabe Y, et al. Peptic ulcer disease mortality. Comparison of native Japanese, Japanese Americans, and Caucasian Americans. J Clin Gastroenterol 1994: 18: 145–54.

    Article  PubMed  CAS  Google Scholar 

  3. Branch MS, Brazer SR, Taylor IL. Peptic ulcer disease: medical and surgical management. In: Gitnik G, editor. Principles and practice of gastroenterology and hepatology. Norwalk (CT): Appleton and Lange, 1994: 141–58.

    Google Scholar 

  4. Tytgat GNJ, Rauws EAJ. Campylobacter pylori and its role in peptic ulcer disease. Gastroenterol Clin North Am. 1990; 19: 183–96.

    PubMed  CAS  Google Scholar 

  5. Soll AH, Weinstein WM, Kurata JH, et al. Nonsteroidal antiinflammatory drugs and peptic ulcer disease. Ann Intern Med. 1991; 114: 307–19.

    PubMed  CAS  Google Scholar 

  6. Malferheiner P, Halter F. Peptic ulcer pathogenesis. Curr Opin Gastroenterol. 1994; 10 Suppl. 196: 30–4.

    Google Scholar 

  7. Sipponen P, Hyvrinen H. Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer. Scand J Gastroenterol. 1993; 28 Suppl. 196: 3–6.

    Article  Google Scholar 

  8. Marshall BJ, Goodwin CS, Warren JR, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet. 1988; I: 1437–41.

    Article  Google Scholar 

  9. George LL, Borody TJ, Andrews P, et al. Cure of duodenal ulcer after eradication of Helicobacter pylori. Med J Aust. 1990; 153: 145–9.

    PubMed  CAS  Google Scholar 

  10. Dixon BE. Pathogenic mechanisms of Helicobacter pylori. Gastroenterol Clin North Am. 1993; 22: 43–57.

    Google Scholar 

  11. Cryer B, Faust T, Goldschmiedt M, et al. Gastric and duodenal mucosal prostaglandin concentrations in gastric or duodenal ulcer disease: relationship with demographics, environmental, and histologic factors, including Helicobacter pylori. Am J Gastroenterol. 1992; 87: 1747–54.

    PubMed  CAS  Google Scholar 

  12. Graham DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology. 1992; 102: 493–6.

    PubMed  CAS  Google Scholar 

  13. Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithellium in active chronic gastritis. Lancet. 1983; I: 1273–5.

    Google Scholar 

  14. Graham DY. Campylobact pylori and peptic ulcer disease. Gastroenterology. 1989; 96: 615–25.

    PubMed  CAS  Google Scholar 

  15. Rauws EAJ, Tytgat GNJ. Cure of duodenal ulcer association with eradication of Helicobater pylori. Lancet. 1990; 335: 1233–5.

    Article  PubMed  CAS  Google Scholar 

  16. Bartlett JC. Campylobacter pylori: fact or fantasy? Gastroenterol. 1988; 94: 229–38.

    CAS  Google Scholar 

  17. Peterson WL. Helicobacter pylori and peptic ulcer disease. N Engl J Med. 1991; 324: 1043–8.

    Article  PubMed  CAS  Google Scholar 

  18. Graham DY. Helicobacter pylori: its epidemiology and its role in duodenal ulcer disease. J Gastroenterol Hepatol. 1991; 6: 105–13.

    Article  PubMed  CAS  Google Scholar 

  19. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991; 325(16): 1127–31.

    Article  PubMed  CAS  Google Scholar 

  20. el-Omar EM, Peman ID, Ardill JE, et al. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterol. 1995; 109: 681–91.

    Article  CAS  Google Scholar 

  21. Fennerty MB. Helicobacter pylori. Arch Intern Med. 1994; 154: 721–7.

    Article  PubMed  CAS  Google Scholar 

  22. Lee A. The microbiology and epidemiology of Helicobacter pylori infection. Scand J Gastroenterol. 1994; 29 Suppl. 201: 2–6.

    Article  Google Scholar 

  23. Lamber JR, Lin SK, Sievert W, et al. High prevalence of Helicobacter pylori antibodies in an institutionalized population: evidence for person to person transmission. Am J Gastroenterol. 1995; 90: 2167–71.

    Google Scholar 

  24. Chisholm MA, Jackson MW. Evaluation of the gastrointestinal tracta. In: DiPiro J, Talbert RJ, Yee GS, et al., editors. Pharmacotherapy: a pathophysiologic approach. 3rd ed. Stamford: Appleton and Lange, 1997; 697–721.

    Google Scholar 

  25. Cutler A, Schubert A, Schubert T. Role of Helicobacter pylori serology in evaluating treatment success. Dig Dis Sci. 1993; 38: 2262–6.

    Article  PubMed  CAS  Google Scholar 

  26. The report of the Digestive Health Initiative International Update Conference on Helicobacter pylori [editorial]. Gastroenterology 1997; 113: S4-S8.

  27. Brown KE, Peura DA. Diagnosis of Helicobacter pylori infection. Gastroenterol Clin North Am. 1993; 22: 105–15.

    PubMed  CAS  Google Scholar 

  28. Marshall BJ, Plankey MW, Hoffman SR, et al. A 20-minute breath test for Helicobacter pylori. Am J Gastroenterol. 1991; 86: 438–45.

    PubMed  CAS  Google Scholar 

  29. Walsh JH, Peterson WL. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med. 1991; 333: 984–91.

    Google Scholar 

  30. National Institutes of Health Consensus Conference. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA. 1994; 272: 65–9.

    Article  Google Scholar 

  31. Fendrick AM, Chernew ME, Hirth RA, et al. Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med. 1995; 123: 260–8.

    PubMed  CAS  Google Scholar 

  32. European Helicobacter pylori Study Group. Current European concepts in the management of Helicobacter pylori infection: the Maastricht consensus report. Gut. 1997; 41: 8–13.

    Article  Google Scholar 

  33. Soll AH. Medical treatment of peptic ulcer disease. JAMA. 1996; 275: 622–9.

    Article  PubMed  CAS  Google Scholar 

  34. deBoer WA, van Etten RJ, Schade RW, et al. 4-day lansoprazole quadruple therapy: a highly effective cure for Helicobacter pylori infection. Am J Gastroenterol. 1996; 91: 1778–82.

    CAS  Google Scholar 

  35. Red Book. Montavale (NJ): Medical Economics Data, 1997.

  36. Berstad A, Hatlebakk JG, Wilhelmsem I, et al. Follow-up on 242 patients with peptic ulcer disease one year after eradication of Helicobacter pylori infection. Hepatogastroenterology. 1995; 45: 655–9.

    Google Scholar 

  37. Ateshkadi A, Lam NP, Johnson CA. Helicobacter pylori and peptic ulcer disease. Clin Pharm. 1993; 12: 32–48.

    Google Scholar 

  38. Coghlan JG, Humphre H, Dobley C, et al. Campylob acter pylori and recurrence of duodenal ulcers — a 12-month follow-up study. Lancet. 1987; II: 1109–11.

    Article  Google Scholar 

  39. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: a randomized, controlled study. Ann Intern Med. 1992; 116(9): 705–8.

    PubMed  CAS  Google Scholar 

  40. Taylor JL, Zagari M, Murphy K, et al. Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori. Arch Intern Med. 1997; 157: 87–97.

    Article  PubMed  CAS  Google Scholar 

  41. Malfertheiner P. Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment. Scand J Gastroenterol. 1993; 28 Suppl. 196: 34–7.

    Article  Google Scholar 

  42. Penston JG. Helicobacter pylori eradication — understandable caution but no excuse for inertia. Aliment Pharmacol Ther. 1994; 8: 369–89.

    Article  PubMed  CAS  Google Scholar 

  43. Lerang F, Mourn B, Haug JB, et al. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance? Am J Gastroenterolt 1997; 92(2): 248–53.

    CAS  Google Scholar 

  44. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994; 89 Suppl. 8: S116–28.

    PubMed  CAS  Google Scholar 

  45. Wilhelmsen I, Berstad A. Quality of life and relapse of duodenal ulcer before and after eradication of Helicobacter pylori. Scand J Gastroenterol. 1994; 29: 874–9.

    Article  PubMed  CAS  Google Scholar 

  46. Wilhelmsen I. Quality of life and Helicobacter pylori eradication. Scand J Gastroenterol. 1996; 221: 18–20.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical and Administrative Sciences, University of Georgia College of Pharmacy, Athens, Georgia, USA

    Marie A. Chisholm (Assistant Professor of Pharmacy) & William E. Wade

  2. Department of Internal Medicine, Medical College of Georgia School of Medicine, CJ-1020, Augusta, Georgia, 30912-2390, USA

    Marie A. Chisholm (Assistant Professor of Pharmacy)

  3. Section of Gastroenterology, Medical College of Georgia, Augusta, Georgia, USA

    Mark W. Jackson

Authors
  1. Marie A. Chisholm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark W. Jackson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. William E. Wade
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marie A. Chisholm.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chisholm, M.A., Jackson, M.W. & Wade, W.E. Eradication of Helicobacter pylori in the Treatment of Uncomplicated Peptic Ulcer Disease. Dis-Manage-Health-Outcomes 3, 191–200 (1998). https://doi.org/10.2165/00115677-199803040-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00115677-199803040-00004

Keywords

Search

Navigation